Biological agents: A novel approach to the therapy of rheumatoid arthritis

Expert Opinion on Investigational Drugs

Volumn 9, Issue 7, 2000, Pages 1479-1490

  Lorenz, H M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Biologics; IL 1RA; Immunotherapy; Monoclonal antibodies; Rheumatoid arthritis; TNF

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; CYTOKINE RECEPTOR; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6 ANTIBODY; LENERCEPT; METHOTREXATE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; HUMAN; INFLAMMATION; JOINT DESTRUCTION; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0033932396     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.7.1479     Document Type: Review

References (68)